Nuvation Bio (NUVB) Competitors $2.67 -0.01 (-0.37%) (As of 12/23/2024 05:26 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NUVB vs. VRNA, RYTM, MLTX, EWTX, JANX, XENE, MRUS, ACAD, TWST, and VCELShould you be buying Nuvation Bio stock or one of its competitors? The main competitors of Nuvation Bio include Verona Pharma (VRNA), Rhythm Pharmaceuticals (RYTM), MoonLake Immunotherapeutics (MLTX), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), Xenon Pharmaceuticals (XENE), Merus (MRUS), ACADIA Pharmaceuticals (ACAD), Twist Bioscience (TWST), and Vericel (VCEL). These companies are all part of the "pharmaceutical products" industry. Nuvation Bio vs. Verona Pharma Rhythm Pharmaceuticals MoonLake Immunotherapeutics Edgewise Therapeutics Janux Therapeutics Xenon Pharmaceuticals Merus ACADIA Pharmaceuticals Twist Bioscience Vericel Verona Pharma (NASDAQ:VRNA) and Nuvation Bio (NYSE:NUVB) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends. Do institutionals and insiders hold more shares of VRNA or NUVB? 85.9% of Verona Pharma shares are held by institutional investors. Comparatively, 61.7% of Nuvation Bio shares are held by institutional investors. 4.8% of Verona Pharma shares are held by company insiders. Comparatively, 5.1% of Nuvation Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate VRNA or NUVB? Verona Pharma currently has a consensus target price of $43.83, indicating a potential downside of 3.19%. Nuvation Bio has a consensus target price of $6.60, indicating a potential upside of 147.19%. Given Nuvation Bio's higher probable upside, analysts clearly believe Nuvation Bio is more favorable than Verona Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Nuvation Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, VRNA or NUVB? Verona Pharma has higher revenue and earnings than Nuvation Bio. Verona Pharma is trading at a lower price-to-earnings ratio than Nuvation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma$5.62M647.64-$54.37M-$1.92-23.58Nuvation Bio$2.16M415.65-$75.80M-$2.17-1.23 Which has more volatility & risk, VRNA or NUVB? Verona Pharma has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Nuvation Bio has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Does the MarketBeat Community prefer VRNA or NUVB? Verona Pharma received 279 more outperform votes than Nuvation Bio when rated by MarketBeat users. Likewise, 80.55% of users gave Verona Pharma an outperform vote while only 78.57% of users gave Nuvation Bio an outperform vote. CompanyUnderperformOutperformVerona PharmaOutperform Votes32380.55% Underperform Votes7819.45%Nuvation BioOutperform Votes4478.57% Underperform Votes1221.43% Is VRNA or NUVB more profitable? Nuvation Bio's return on equity of -21.89% beat Verona Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Verona PharmaN/A -79.54% -43.49% Nuvation Bio N/A -21.89%-17.86% Does the media prefer VRNA or NUVB? In the previous week, Nuvation Bio had 3 more articles in the media than Verona Pharma. MarketBeat recorded 8 mentions for Nuvation Bio and 5 mentions for Verona Pharma. Verona Pharma's average media sentiment score of 0.50 beat Nuvation Bio's score of 0.44 indicating that Verona Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verona Pharma 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nuvation Bio 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryVerona Pharma beats Nuvation Bio on 9 of the 16 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUVB vs. The Competition Export to ExcelMetricNuvation BioPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$898.63M$6.69B$5.20B$19.22BDividend YieldN/A3.00%5.12%3.67%P/E Ratio-1.2310.5287.1941.09Price / Sales415.65193.661,163.5517.39Price / CashN/A57.1643.2321.28Price / Book0.975.134.805.31Net Income-$75.80M$151.58M$120.46M$989.88M7 Day Performance-5.15%-1.40%-0.89%-2.50%1 Month Performance-4.64%-3.69%14.87%-4.68%1 Year Performance79.19%9.07%29.57%11.56% Nuvation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUVBNuvation Bio2.3775 of 5 stars$2.67-0.4%$6.60+147.2%+79.2%$898.63M$2.16M-1.2360Analyst ForecastNews CoverageVRNAVerona Pharma0.9464 of 5 stars$43.32+4.6%$43.83+1.2%+157.9%$3.52B$460,000.00-21.5730RYTMRhythm Pharmaceuticals4.1031 of 5 stars$56.23+1.8%$63.70+13.3%+20.9%$3.46B$77.43M-12.76140Analyst ForecastNews CoveragePositive NewsMLTXMoonLake Immunotherapeutics1.6314 of 5 stars$52.07+1.4%$79.88+53.4%-13.3%$3.33BN/A-39.802EWTXEdgewise Therapeutics2.4982 of 5 stars$34.97+26.6%$42.33+21.1%+221.3%$3.31BN/A-22.8560Gap UpHigh Trading VolumeJANXJanux Therapeutics3.695 of 5 stars$62.25+1.9%$89.90+44.4%+436.9%$3.27B$13.05M-52.2330Positive NewsXENEXenon Pharmaceuticals2.8295 of 5 stars$41.15+2.7%$56.90+38.3%-14.5%$3.14B$9.43M-14.20251MRUSMerus2.2316 of 5 stars$42.84+0.0%$85.64+99.9%+56.8%$2.93B$43.95M-10.8437ACADACADIA Pharmaceuticals3.8669 of 5 stars$17.50+1.4%$25.60+46.3%-45.3%$2.91B$726.44M22.13510TWSTTwist Bioscience2.5927 of 5 stars$48.94+3.0%$51.90+6.0%+30.9%$2.91B$312.97M-13.19990VCELVericel1.2838 of 5 stars$58.15+1.2%$59.71+2.7%+64.1%$2.87B$226.84M957.83300Analyst Upgrade Related Companies and Tools Related Companies Verona Pharma Alternatives Rhythm Pharmaceuticals Alternatives MoonLake Immunotherapeutics Alternatives Edgewise Therapeutics Alternatives Janux Therapeutics Alternatives Xenon Pharmaceuticals Alternatives Merus Alternatives ACADIA Pharmaceuticals Alternatives Twist Bioscience Alternatives Vericel Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NUVB) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.